4
Changes in Ownership
Grace Therapeutics, Inc. Filed Acc 0001493152-26-046899
10% owner bought 14,632 shares at an average $2.03 ($29,683)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. 10% owner | 2026-10-08 | Purchase | +2,077 | $2.02 | $4,190 | 2,860,734 | I |
| Opaleye Management Inc. 10% owner | 2026-10-09 | Purchase | +5,340 | $2.04 | $10,918 | 2,866,074 | I |
| Opaleye Management Inc. 10% owner | 2026-10-12 | Purchase | +7,215 | $2.02 | $14,574 | 2,873,289 | I |
| Open-market purchases · 14,632 sh · avg $2.03 · $29,683 | |||||||
Loading xslF345X06/ownership.xml…